StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of SRNE opened at $0.31 on Friday. The company has a quick ratio of 0.79, a current ratio […]
Analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Up 2.9 % Shares of SRNE opened at $0.32 on Monday. The firm has a […]
Analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 20.3 % Shares of NASDAQ:SRNE opened at $0.31 on Friday. The business’s 50 day moving average is $0.31 and its […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 20.3 % SRNE opened at $0.31 on Thursday. The stock’s fifty day simple moving average is $0.31 and its […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research report released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Shares of Sorrento Therapeutics stock opened at $0.31 on Thursday. Sorrento Therapeutics has a 12-month low of $0.16 and a 12-month […]